1. Home
  2. REFI vs ANIK Comparison

REFI vs ANIK Comparison

Compare REFI & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chicago Atlantic Real Estate Finance Inc.

REFI

Chicago Atlantic Real Estate Finance Inc.

HOLD

Current Price

$10.15

Market Cap

241.1M

Sector

Real Estate

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$21.91

Market Cap

200.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REFI
ANIK
Founded
2021
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
241.1M
200.9M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
REFI
ANIK
Price
$10.15
$21.91
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$17.00
AVG Volume (30 Days)
153.8K
96.9K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
15.79%
N/A
EPS Growth
N/A
80.16
EPS
0.57
N/A
Revenue
$48,857,628.00
$112,819,000.00
Revenue This Year
$17.47
$5.98
Revenue Next Year
$0.06
$7.42
P/E Ratio
$18.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.69
$8.22
52 Week High
$14.57
$22.88

Technical Indicators

Market Signals
Indicator
REFI
ANIK
Relative Strength Index (RSI) 44.72 68.96
Support Level $9.69 $14.13
Resistance Level $12.45 N/A
Average True Range (ATR) 0.23 1.42
MACD 0.07 0.30
Stochastic Oscillator 56.10 85.49

Price Performance

Historical Comparison
REFI
ANIK

About REFI Chicago Atlantic Real Estate Finance Inc.

Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. The Company operates as one operating segment, and its primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time, mainly through consistent current income (dividends and distributions) and secondarily, through capital appreciation. The company operates mainly within the USA itself.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: